StockData
Surgery Partners, Inc. logo

Surgery Partners, Inc. (SGRY) stock

SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/3011% above fair value
$26.96+0.11 (+0.41%)

Close on Nov 18, 2026Market cap $3.53BP/E –Yield –

Surgery Partners operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Surgery Partners's operating income for the twelve months ending Jun 30, 2026 was $383.80M, up 6.1% year over year. For fiscal 2025 it was $389.50M, up 11.7% from the year before. Over ten years it grew 22.6% a year on average. The highest annual figure on record is $389.50M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$389.50M+11.7%
FY2024Dec 31, 2024$348.80M+6.3%
FY2023Dec 31, 2023$328.00M-5.0%
FY2022Dec 31, 2022$345.20M+14.2%
FY2021Dec 31, 2021$302.20M+65.1%
FY2020Dec 31, 2020$183.00M-22.4%
FY2019Dec 31, 2019$235.90M+203.2%
FY2018Dec 31, 2018$77.80M-60.4%
FY2016Dec 31, 2016$196.48M+35.7%
FY2015Dec 31, 2015$144.75M+184.9%
FY2014Dec 31, 2014$50.81M-12.7%
FY2013Dec 31, 2013$58.23M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$102.10M-8.6%
Q1 FY2026Mar 31, 2026$65.80M+6.3%
Q4 FY2025Dec 31, 2025$110.20M-13.3%
Q3 FY2025Sep 30, 2025$105.70M+73.6%
Q2 FY2025Jun 30, 2025$111.70M+31.7%
Q1 FY2025Mar 31, 2025$61.90M-18.6%
Q4 FY2024Dec 31, 2024$127.10M+25.3%
Q3 FY2024Sep 30, 2024$60.90M-26.3%
Q2 FY2024Jun 30, 2024$84.80M-13.1%
Q1 FY2024Mar 31, 2024$76.00M+63.8%
Q4 FY2023Dec 31, 2023$101.40M+7.6%
Q3 FY2023Sep 30, 2023$82.60M+11.5%
Q2 FY2023Jun 30, 2023$97.60M+27.6%
Q1 FY2023Mar 31, 2023$46.40M-53.8%
Q4 FY2022Dec 31, 2022$94.20M-17.9%
Q3 FY2022Sep 30, 2022$74.10M+16.5%
Q2 FY2022Jun 30, 2022$76.50M+28.6%
Q1 FY2022Mar 31, 2022$100.40M+56.1%
Q4 FY2021Dec 31, 2021$114.80M+19.2%
Q3 FY2021Sep 30, 2021$63.60M+243.8%
Q2 FY2021Jun 30, 2021$59.50M+33.1%
Q1 FY2021Mar 31, 2021$64.30M+173.6%
Q4 FY2020Dec 31, 2020$96.30M+34.1%
Q3 FY2020Sep 30, 2020$18.50M-68.6%
Q2 FY2020Jun 30, 2020$44.70M-19.5%
Q1 FY2020Mar 31, 2020$23.50M-52.6%
Q4 FY2019Dec 31, 2019$71.80M–
Q3 FY2019Sep 30, 2019$59.00M+31.1%
Q2 FY2019Jun 30, 2019$55.50M+27.6%
Q1 FY2019Mar 31, 2019$49.60M+20.4%
Q4 FY2018Dec 31, 2018-$51.90M-237.5%
Q3 FY2018Sep 30, 2018$45.00M+7.9%
Q2 FY2018Jun 30, 2018$43.50M-36.4%
Q1 FY2018Mar 31, 2018$41.20M-3.8%
Q2 FY2017Jun 30, 2017$37.74M–
Q1 FY2017Mar 31, 2017$41.72M–
Q4 FY2016Dec 31, 2016$68.41M–
Q3 FY2016Sep 30, 2016$42.85M–

More Surgery Partners figures

See a number that looks wrong?